Autologous stem cell transplantation for clinically aggressive non-Hodgkin's lymphoma: the role of preparative regimens

Bone Marrow Transplantation
A SalarGEL/TAMO Spanish Cooperative Group

Abstract

We investigated the impact of the most commonly used preparative regimens on the outcome of 395 patients with diffuse large cell lymphoma (DLCL), consecutively reported to the registry of the Spanish GEL/TAMO. Among them, 139 (35%) were autografted in 1st CR, 86 (22%) in 2nd/3rd CR, 124 (31%) had chemosensitive disease and 46 (12%) had chemoresistant disease. Conditioning consisted of chemotherapy-only in 348 patients (BEAM, 164; BEAC, 145; and CBV, 39) and radiochemotherapy with CY and TBI in 47. Median times to granulocyte, platelet recovery and to discharge were significantly shorter in the chemotherapy-only group. Early transplant-related mortality was significantly higher when using CY-TBI. After a median follow-up of 28 months, overall survival (OS) at 8 years of patients conditioned with BEAM or BEAC (58% (95% CI 50-66%)) was more favorable than with CBV (40% (95% CI 24-56%)), and significantly better than with CY-TBI (31% (95% CI 18-44%)). Multivariate analysis revealed that patients conditioned with chemotherapy-only regimens had improved OS, disease-free (DFS) and relapse-free survival (RFS) when compared to those conditioned with CY-TBI. Status at transplant was also a powerful prognostic indicator. We conclude that ...Continue Reading

References

Jun 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S GulatiE Hanninen
Apr 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F B PetersenR Storb
Sep 1, 1987·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F R AppelbaumJ E Sanders
Apr 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·I A CooperF C Firkin
Mar 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W MillsA H Goldstone
Dec 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R M StoneA S Freedman
Jun 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C WheelerJ P Eder
Oct 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J M VoseJ O Armitage
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN International Non-Hodgkin's Lymphoma Prognostic Factors Project
Jun 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W S VelasquezF Cabanillas
Dec 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A P RapoportM A Tanner
May 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A S FreedmanM J Robertson
Feb 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R PettengellD Crowther
May 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A M StoppaD Maraninchi
Oct 21, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C GuglielmiF Chauvin

❮ Previous
Next ❯

Citations

Jun 1, 2007·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Sook Hee HongChun Choo Kim
Mar 22, 2012·Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation·Mani RamziHoorvash Haghighinejad
Apr 17, 2013·Expert Opinion on Biological Therapy·Tiziana MoscatoMassimo Martino
Sep 12, 2014·Annals of Medicine·Mehdi Hamadani
Feb 9, 2010·International Journal of Radiation Oncology, Biology, Physics·Hong-Wei LiuAndrew Cooke
Feb 18, 2015·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Yi-Bin ChenMarcelo C Pasquini
May 11, 2013·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Philip L McCarthyNavneet S Majhail
Aug 27, 2002·Cytotherapy·S M SmithK van Besien
Feb 14, 2015·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Veronika BachanovaJatinder Kaur Lamba
Mar 27, 2007·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Rachel E LernerLinda J Burns
Nov 16, 2010·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Gordon L PhillipsJonathan W Friedberg
Aug 3, 2010·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Partow KebriaeiBorje S Andersson
Dec 31, 2004·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Punit D WadhwaHillard M Lazarus
May 16, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christian GisselbrechtUNKNOWN Groupe d'Etude des Lymphomes de l'Adulte
Oct 28, 2017·Cancer Medicine·Ana Jiménez-UbietoUNKNOWN GELTAMO (Grupo Español de Linfomas y Trasplantes de Médula Ósea) cooperative study group
Jul 27, 2004·Bone Marrow Transplantation·E H WangE Carrier
Mar 30, 2019·Experimental Hematology & Oncology·Mattias CarlstenBjörn Engelbrekt Wahlin
Mar 13, 2021·Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion·Ahmet Kursad GunesGulsum Ozet

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Brain Injury & Trauma

brain injury after impact to the head is due to both immediate mechanical effects and delayed responses of neural tissues.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.